Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro.

Yihua Sun,Rong Fang,Chenguang Li,Li Li,Fei Li,Xiaolei Ye,Haiquan Chen
DOI: https://doi.org/10.1016/j.bbrc.2010.04.127
IF: 3.1
2010-01-01
Biochemical and Biophysical Research Communications
Abstract:Lung cancer is one of the most devastating diseases worldwide. RGS17 is previously shown to be over-expressed in human lung adenocarcinomas and plays an important role in lung tumor growth. Here we have identified a miRNA, has-mir-182, involved in the regulation of RGS17 expression through two conserved sites located in its 3' UTR region. Consistently, endogenous RGS17 expression level is regulated by hsa-mir-182 in human lung cancer cell lines. Similar to the knockdown of RGS17, ectopic expression of hsa-mir-182 significantly inhibits lung cancer cell proliferation and anchorage-independent cell growth, which can be rescued by re-expression of RGS17. Taken together, these data have provided the first evidence of miRNA regulation of RGS17 expression in lung cancer.
What problem does this paper attempt to address?